Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
1,827,584
-
Shares change
-
-7,228
-
Total reported value, excl. options
-
$2,467,000
-
Value change
-
-$8,666
-
Number of buys
-
5
-
Number of sells
-
-4
-
Price
-
$1.35
Significant Holders of ProPhase Labs, Inc. - COM (PRPH) as of Q2 2015
14 filings reported holding PRPH - ProPhase Labs, Inc. - COM as of Q2 2015.
ProPhase Labs, Inc. - COM (PRPH) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,827,584 shares
.
Largest 10 shareholders include MORGAN STANLEY (682,400 shares), Vantage Investment Partners, LLC (437,915 shares), Bank of New York Mellon Corp (193,484 shares), DIMENSIONAL FUND ADVISORS LP (157,158 shares), VANGUARD GROUP INC (130,494 shares), RENAISSANCE TECHNOLOGIES LLC (61,200 shares), PNC Financial Services Group, Inc. (60,000 shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (47,401 shares), UBS Group AG (20,500 shares), and Commonwealth Equity Services, Inc (19,305 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.